News Announcement

Aspira Pathlab & Diagnostics: Non-Applicability Of Related Party Transactions Under Regulation 23 (9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 ('SEBI (LODR) Regulations 2015')

This is in reference to the captioned subject in connection with the non-applicability of Regulations 23(9) of SEBI (LODR) Regulations 2015. We respectfully submit that as the Company falls under criteria as specified under the Regulations 15 (2) of SEBI (LODR) Regulations 2015 and the paid up equity share capital and net worth of the Company was below Rs. 10 Crores and 25 Crores respectively as on 31st March 2020 and thus not required to submit the related party transaction disclosures as required under Regulation 23(9) of SEBI (LODR) Regulations 2015
The paid up equity share capital and net worth of the Company as on 31st March 2020 (Previous Financial Year) was Rs. 9 29 30 000/- (Rupees Nine Crores Twenty Nine Lakhs Thirty Thousand) and Rs. 3 80 08 830/- (Rupees Three Crores Eighty Lakhs Eight Thousand Eight Hundred Thirty ) respectively.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.